Eric Roberts shares PULS Cardiac Test story with Lifescript

Actor credits innovative blood test with saving his life
(PR NewsChannel) / June 28, 2016 / LOS ANGELES 

GD Bioscience PULS Cardiac TestWhen Golden Globe nominated actor Eric Roberts attended the 2013 Academy Awards he didn’t think he would be taking something home far more valuable than a gold statue… a new lease on life.

Before the award ceremony that night the 60-year-old actor was pulled into a gifting suite which administered the PULS Cardiac test, an innovative blood test that can measure heart attack risk. Although he didn’t expect anything to come of it, the test revealed that he was on the brink of having a cardiac event that could have cost him his life.

Now with his heart scare behind him, he’s telling his story to the women’s health website Lifescript in hopes that his cautionary tale can help save others.

(Click here to read the full story on Lifescript)

“Mr. Roberts’ story is one that we see a lot,” says Dr. Douglas Harrington, CEO at Global Discovery (GD) Biosciences, the company behind the revolutionary test. “Many patients believe that they are in great shape and therefore not at risk for any heart trouble. Unfortunately, often times that doesn’t prove to be the case.”

Heart disease remains the leading cause of death and disability worldwide, but is 80% preventable with early detection and lifestyle modifications. A major issue for physicians is being able to accurately detect the disease, since most patients present with no signs or symptoms before a fatal or debilitating heart attack.

In fact, a recent study by from the Atherosclerosis Risk in Communities (ARIC) has found that nearly half of all heart attacks appear to be clinically “silent,” meaning they aren’t associated with any easily identifiable symptoms.

Luckily, the PULS Cardiac Test can predict the likelihood patients will experience an Acute Coronary Syndrome (ACS event) within a 5-year period. This helps to identify vulnerable patients before they have a cardiac event and lets physicians improve patient care by giving them an opportunity to implement potentially life-saving prevention plans.

The PULS Cardiac Test is a non-invasive blood test that measures the body’s immune response to coronary artery injury in patients with no symptoms of heart disease. The body’s response to coronary artery injury frequently causes formation of lesions in the coronary artery wall, which may become unstable and rupture, leading to the formation of a blood clot, the most common cause of heart attacks.

For more information, or to request testing, please visit:

About GD Biosciences

Global Discovery Biosciences (GD Biosciences) is a pioneer in the field of diagnostic medicine. The company works on the cutting edge of medical research, turns discoveries into innovative products and brings those products to the global marketplace.

The company works with advanced research teams to develop, manufacture and distribute innovative technology platforms to address the needs of the global disease burden. Its CLIA-certified and GMP laboratory performs a menu of clinically effective tests targeting key health issues. Our goal is to equip physicians with the tools they need to transform health care – one patient at a time.

About the PULS Cardiac Test

The PULS Cardiac Test is a simple blood test that uses breakthrough medical technology to identify individuals with active, yet undetected subclinical Coronary Heart Disease (CHD), who are at risk of experiencing a Heart Attack, and for whom early intervention can help. The test uses 9 clinically-significant protein biomarkers to measure the body’s immune system response to arterial injury leading to the formation of unstable cardiac lesions – the cause of 75% of all Heart Attacks.

Check out our recent news coverage:
Fox News Special Report – Technology Helps Predict Heart Attacks
Travel Pulse – Could Blood Test Warn Pilots of Heart Attack Risk?
Times Colonist – Blood test can assess Heart Attack risk, conference told
Saskatoon Star Phoenix – New test for Heart Attack risk
The Province – Blood test can assess Heart Attack risk, Vancouver conference hears

Adam Farragut
PR Firm: The Publicity Agency
Phone: 813-708-1220 x7778


Direct link:

SOURCE:  GD Biosciences

This press release is distributed by PR NewsChannel. Your News. Everywhere.